Next-generation sequencing technologies have helped scientists establish causal relationships between genetic aberrations and disease. Researchers have expanded sequencing technologies to detect epigenetic modifications and study their links to disease through epigenome-wide association studies (EWAS). Such studies typically use bisulfite sequencing to detect DNA methylation, but this technology cannot distinguish between 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC), two important DNA-based epigenetic modifications.
Download this application note from Tecan to discover
The Scientist c/o LabX Media Group
1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801
Toll Free: 888.788.0328 | Phone: 705.528.6888
Email: privacy@the-scientist.com
© 1986-2022 The Scientist
The Scientist needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.